Kairos Pharma, LTD. (KAPA)

Latest Insider Confidence Score

2025Q4

50.2
Bullish

Company insider confidence (by quarter)

2024Q3 2025Q4

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Yu John S CEO 5,316,572 Nov 26, 2025
Bhowmick Neil 1,139,983 Apr 7, 2025
Murali Ramachandran VP of Research and Development 299,529 Nov 26, 2025
Samuelson Doug CFO 293,039 Nov 26, 2025
Singhvi Rahul 49,204 Nov 26, 2025

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Oct 8, 2025 Dec 30, 2025 Bhowmick Neil Chief Scientific Officer Neutral 90.0 +171,756 15.07% -
Sep 16, 2025 Dec 23, 2025 Bae Hyun W. Director Neutral 90.0 +29,084 65.67% -
Oct 8, 2025 Nov 26, 2025 Murali Ramachandran VP of Research and Development Neutral 90.0 +152,672 103.96% -
Sep 16, 2025 Nov 26, 2025 Keyoung Hansoo Michael Director Neutral 90.0 +29,084 100.00% -
Oct 8, 2025 Nov 26, 2025 Singhvi Rahul Director Neutral 90.0 +19,084 63.36% -
Oct 8, 2025 Nov 26, 2025 Samuelson Doug CFO Neutral 90.0 +152,672 108.77% -
Oct 8, 2025 Nov 26, 2025 Yu John S CEO Neutral 82.5 +190,840 3.56% -
Apr 30, 2025 Singhvi Rahul Director Neutral 52.5 - 0.00% -
Jan 1, 2025 Apr 7, 2025 Bhowmick Neil Chief Scientific Officer Neutral 77.5 +14,000 1.24% -
Jan 1, 2025 Feb 24, 2025 Murali Ramachandran VP of Research and Development Neutral 90.0 +14,000 10.52% -
Jan 1, 2025 Feb 24, 2025 Yu John S CEO Neutral 60.0 +14,000 0.26% -
Nov 25, 2024 Nov 25, 2024 Murali Ramachandran VP of Research and Development Buy 55.0 +200 0.15% $318
Nov 22, 2024 Nov 25, 2024 Samuelson Doug CFO Buy 82.5 +2,500 4.29% $3.8K
Nov 20, 2024 Nov 21, 2024 Yu John S CEO Buy 55.0 +4,000 0.07% $5.8K
Sep 24, 2024 Bhowmick Neil Chief Scientific Officer Neutral 52.5 - 0.00% -
Sep 24, 2024 MAZANET ROSEMARY Director Neutral 52.5 - 0.00% -
Sep 24, 2024 Murali Ramachandran VP of Research and Development Neutral 52.5 - 0.00% -
Sep 24, 2024 Keyoung Hansoo Michael Director Neutral 52.5 - 0.00% -
Sep 24, 2024 Samuelson Doug CFO Neutral 52.5 - 0.00% -
Sep 24, 2024 Yu John S CEO Neutral 52.5 - 0.00% -
Sep 24, 2024 Bae Hyun W. Director Neutral 52.5 - 0.00% -